Last edition
News about "AI-powered drug discovery"
Daiichi Sankyo Partners with Imagene AI for Biomarker Discovery
Through collaboration, Imagene AI and Daiichi Sankyo will apply multimodal AI to improve biomarker discovery with the goals of advancing precision oncology and enhancing clinical trial success rates.
AI-powered Drug Discovery | 11/04/2026 | By News Bureau | 148
Illumina Launches BioInsight to Drive Multiomic Data and AI-Powered Drug Discovery
Illumina, Inc., a global leader in genomics and precision health, has announced the launch of BioInsight, a new business designed to meet the growing demand for deeper biological insights driven by large-scale multiomic data.
AI-Powered Drug Discovery | 04/10/2025 | By Darshana | 824
Parexel Partners with Weave Bio to Accelerate Regulatory Submissions Using AI
Parexel, a leading global clinical research organisation, has announced a partnership with Weave Bio, an AI-native regulatory automation specialist, aimed at speeding up regulatory submission processes and reducing time to market for new therapies.
AI-Powered Drug Discovery | 03/10/2025 | By Darshana | 378
Indegene Acquires BioPharm for USD 106 Million to Bolster AI-Driven Pharma Marketing
This deal strengthens Indegene’s commercial capabilities by combining its data, analytics and AI platforms with BioPharm’s expertise in omnichannel marketing, media strategy and precision engagement with healthcare providers.
AI-Powered Drug Discovery | 03/10/2025 | By Darshana | 338
Eli Lilly Manufactures Access to AI-Powered Drug Discovery with Launch of TuneLab Platform
The initiative allows smaller biotechnology firms to utilise AI models developed from over a billion dollars of Eli Lilly’s proprietary research—historical investment that has yielded vast datasets derived from experiments on hundreds of thousands of unique molecules.
AI-Powered Drug Discovery | 10/09/2025 | By Darshana | 348
BioDuro and Atombeat Partner to Launch AI-Driven Platform for Next-Gen Peptide Drug Manufacturing
BioDuro, a globally trusted contract research, development, and manufacturing organization (CRDMO), has announced a strategic partnership with Atombeat Inc., a leader in AI-powered drug discovery. Together, they aim to launch an end-to-end platform for accelerated peptide drug discovery and development.
AI-powered Drug Discovery | 04/08/2025 | By Darshana | 252
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy